What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK
Introduction Obesity is a critical public health challenge globally. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated significant efficacy in weight loss; however, their adoption is influenced by various individual and societal factors. This study sought to examine awareness, m...
Saved in:
Main Authors: | Ashley Kieran Clift, Austen El-Osta, Vivian N Liu, David Roy Huang, Nadja Auerbach, Mahmoud Al-Ammouri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-07-01
|
Series: | BMJ Public Health |
Online Access: | https://bmjpublichealth.bmj.com/content/3/2/e002519.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine.
by: Zaher Merhi, et al.
Published: (2025-01-01) -
Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials
by: Mahmoud H. Elbatreek
Published: (2024-12-01) -
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01) -
Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment
by: Łukasz Zdziebkowski, et al.
Published: (2025-07-01) -
Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review
by: Bisma Fatima Hammad, et al.
Published: (2025-07-01)